Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1986Annual Review of Immunology

Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes

View Full Paper
Ask AI
Bookmark
Share

Authors

Steven A. Rosenberg
Steven A. RosenbergNational Institutes of Health
Michael T. Lotze
Michael T. LotzeRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosenberg et al. (1986) studied this question.

synapsesocial.com/papers/6a171b4fc23c548e2a7bc33fhttps://doi.org/10.1146/annurev.iy.04.040186.003341
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated <i>in vitro</i> with phytohemagglutinin.1983 · 62 citations
  2. 2Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells1984 · 116 citations
  3. 3Site-Specific Mutagenesis of the Human Interleukin-2 Gene: Structure-Function Analysis of the Cysteine Residues1984 · 327 citations
  4. 4<i>In vitro</i> growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.1980 · 264 citations